Literature DB >> 17142456

Effects of ubiquitin system alterations on the formation and loss of a yeast prion.

Kim D Allen1, Tatiana A Chernova, E Paula Tennant, Keith D Wilkinson, Yury O Chernoff.   

Abstract

The yeast prion [PSI+] is a self-propagating amyloidogenic isoform of the translation termination factor Sup35. Overproduction of the chaperone protein Hsp104 results in loss of [PSI+]. Here we demonstrate that this effect is decreased by deletion of either the gene coding for one of the major yeast ubiquitin-conjugating enzymes, Ubc4, or the gene coding for the ubiquitin-recycling enzyme, Ubp6. The effect of ubc4Delta on [PSI+] loss was increased by depletion of the Hsp70 chaperone Ssb but was not influenced by depletion of Ubp6. This indicates that Ubc4 affects [PSI+] loss via a pathway that is the same as the one affected by Ubp6 but not by Ssb. In the presence of Rnq1 protein, ubc4Delta also facilitates spontaneous de novo formation of [PSI+]. This stimulation is independent of [PIN+], the prion isoform of Rnq1. Numerous attempts failed to detect ubiquitinated Sup35 in the yeast extracts. While ubc4Delta and other alterations of ubiquitin system used in this work cause slight induction of some Hsps, these changes are insufficient to explain their effect on [PSI+]. However, ubc4Delta increases the proportion of the Hsp70 chaperone Ssa bound to Sup35, suggesting that misfolded Sup35 is either more abundant or more accessible to the chaperones in the absence of Ubc4. The proportion of [PSI+] cells containing large aggregated Sup35 structures is also increased by ubc4Delta. We propose that UPS alterations induce an adaptive response, resulting in accumulation of the large "aggresome"-like aggregates that promote de novo prion generation and prion recovery from the chaperone treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142456     DOI: 10.1074/jbc.M609597200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Modulation and elimination of yeast prions by protein chaperones and co-chaperones.

Authors:  Michael Reidy; Daniel C Masison
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

Review 2.  Patterns of [PSI (+) ] aggregation allow insights into cellular organization of yeast prion aggregates.

Authors:  Jens Tyedmers
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 3.  Prions of fungi: inherited structures and biological roles.

Authors:  Reed B Wickner; Herman K Edskes; Frank Shewmaker; Toru Nakayashiki
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

4.  Sti1 regulation of Hsp70 and Hsp90 is critical for curing of Saccharomyces cerevisiae [PSI+] prions by Hsp104.

Authors:  Michael Reidy; Daniel C Masison
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

5.  Curing of the [URE3] prion by Btn2p, a Batten disease-related protein.

Authors:  Dmitry S Kryndushkin; Frank Shewmaker; Reed B Wickner
Journal:  EMBO J       Date:  2008-10-02       Impact factor: 11.598

Review 6.  Protein inheritance (prions) based on parallel in-register beta-sheet amyloid structures.

Authors:  Reed B Wickner; Frank Shewmaker; Dmitry Kryndushkin; Herman K Edskes
Journal:  Bioessays       Date:  2008-10       Impact factor: 4.345

Review 7.  Prions in yeast.

Authors:  Susan W Liebman; Yury O Chernoff
Journal:  Genetics       Date:  2012-08       Impact factor: 4.562

8.  The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.

Authors:  John A Pezza; Sara X Langseth; Rochele Raupp Yamamoto; Stephen M Doris; Samuel P Ulin; Arthur R Salomon; Tricia R Serio
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

Review 9.  Hsp104 and prion propagation.

Authors:  Nina V Romanova; Yury O Chernoff
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

10.  Extra N-terminal residues have a profound effect on the aggregation properties of the potential yeast prion protein Mca1.

Authors:  Marc Erhardt; Renee D Wegrzyn; Elke Deuerling
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.